Umban, Shirlyn A.

HRN: 29-08-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/17/2026
06/23/2026
IV
4.5gm
Q6
Necrotizing Faciitis
Checking Initial Appropriateness 
06/17/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/17/2026
06/23/2026
IV
600mg
Q8
Necrotizing Faciitis
Checking Initial Appropriateness 
06/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2026
06/28/2026
IV
500mg
Q6
Infected Wound Inguinal Area Right
Checking Initial Appropriateness 
06/24/2026
MUPIROCIN 2%, 15G (TUBE)
06/24/2026
06/28/2026
INTRANASAL
4%
BID
Necritzing
Checking Initial Appropriateness 
07/02/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/02/2026
07/08/2026
IV
4.5g
Q6
Necrotizing Fasciitis
Checking Initial Appropriateness 
07/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2026
07/17/2026
IV
4.5g
Q6
Necrotizing Fasciitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: